Nuveen Asset Management
PRVL

Nuveen Asset Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Nuveen Asset Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
2020
Q4 		$1.1M Sell
2020
Q3 		$1.03M Buy
2020
Q2 		$948K Buy
2020
Q1 		$606K Buy
2019
Q4 		$282K Sell
2019
Q3 		$299K Buy